{"nct_id":"NCT02009488","title":"Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2014-09-08","start_date_type":"ACTUAL","primary_completion_date":"2017-01-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}